• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIABETES CARE LTD FREESTYLE LIBRE 3; CONTINUOUS GLUCOSE MONITORING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIABETES CARE LTD FREESTYLE LIBRE 3; CONTINUOUS GLUCOSE MONITORING SYSTEM Back to Search Results
Model Number 72075-01
Medical Device Problem Code Application Program Problem (2880)
Health Effect - Clinical Codes Hyperglycemia (1905); Convulsion/Seizure (4406)
Date of Event 04/01/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Extended investigation is pending at this time.A follow up will be submitted once additional information is obtained.The device manufacturing date does not apply.The date entered in section h4 is the date abbott diabetes care became aware of the event.All pertinent information available to abbott diabetes care has been submitted.
 
Event or Problem Description
An incompatibility issue was reported with the abbott diabetes care (adc) application, in use with an unspecified phone.As a result, the customer was unable to check glucose and experienced a seizure however, the customer was able to self treat with "fast acting" insulin provided by a non-healthcare professional.The customer then had a contact with a healthcare professional (hcp) who obtained a blood glucose result of 286 mg/dl but no treatment was reported.There was no report of death or permanent impairment associated with this event.
 
Event or Problem Description
An incompatibility issue was reported with the abbott diabetes care (adc) application, in use with an unspecified phone.As a result, the customer was unable to check glucose and experienced a seizure however, the customer was able to self treat with "fast acting" insulin provided by a non-healthcare professional.The customer then had a contact with a healthcare professional (hcp) who obtained a blood glucose result of 286 mg/dl but no treatment was reported.There was no report of death or permanent impairment associated with this event.
 
Additional Manufacturer Narrative
The user reported unknown or unspecified issue.The reported issue was investigated and attempted to be replicated.The reported configuration was not compatible with the customer's reported application.The latest revision of the compatibility guide is available to the customer on the abbott diabetes care website.As the compatibility guide is provided to the customer and the incompatible configurations were used, this complaint is not confirmed to use.All pertinent information available to abbott diabetes care has been submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE LIBRE 3
Common Device Name
CONTINUOUS GLUCOSE MONITORING SYSTEM
Manufacturer (Section D)
ABBOTT DIABETES CARE LTD
range road
witney 12345 -700
UK  12345-7001
Manufacturer Contact
audra fuentes
1360 south loop road
alameda, CA 94502-7001
5107495297
MDR Report Key19165383
Report Number2954323-2024-13898
Device Sequence Number7873626
Product Code QBJ
UDI-Device Identifier00357599816001
UDI-Public00357599816001
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K223435
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 06/27/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model Number72075-01
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/01/2024
Supplement Date Received by Manufacturer06/26/2024
Initial Report FDA Received Date04/23/2024
Supplement Report FDA Received Date06/27/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/01/2024
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexFemale
-
-